Here’s Why Vertex Pharmaceuticals Incorporated (VRTX) Slid in Q3

Published on 19 Dec 2024 on Insider Monkey · via Yahoo Finance

Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston...

Read the rest of the article

Start tracking your investments with Statfolio

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shareholders might be concerned after seeing th...

Simply Wall St. · via Yahoo Finance 31 Dec 2024

We recently compiled a list of the Jim Cramer Discusses 17 Stocks And Blasts Zero Day Options. In...

Insider Monkey · via Yahoo Finance 25 Dec 2024

We recently compiled a list of the 10 Stocks That Will Make You Rich In 2025. In this article, we...

Insider Monkey · via Yahoo Finance 24 Dec 2024

On Monday, Truist Securities adjusted its price target for Vertex Pharmaceuticals (NASDAQ:VRTX)...

Investing.com 23 Dec 2024

The FDA's nod is based on late-stage data, which show that treatment with VRTX's Alyftrek enhance...

Zacks · via Yahoo Finance 23 Dec 2024

We recently compiled a list of the Jim Cramer Talked About These 17 Stocks After The Fed’s Rate C...

Insider Monkey · via Yahoo Finance 23 Dec 2024

Vertex announces data from a phase II study evaluating its NaV1.8 pain signal inhibitor,...

Zacks · via Yahoo Finance 20 Dec 2024

On Thursday, BofA Securities adjusted its outlook on Vertex Pharmaceuticals (NASDAQ:VRTX), reduci...

Investing.com 19 Dec 2024

Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnsto...

Insider Monkey · via Yahoo Finance 19 Dec 2024

On Thursday, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced results from its Phase 2...

Benzinga · via Yahoo Finance 19 Dec 2024